SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
SC 13D/A	An amendment to a SC 13D filing	Feb 13, 2019	View HTML 0001193125-19-037699.pdf 0001193125-19-037699.rtf 0001193125-19-037699.xls
8-K	Report of unscheduled material events or corporate event	Feb 19, 2019	View HTML 0001193125-19-044197.pdf 0001193125-19-044197.rtf 0001193125-19-044197.xls
8-K	Report of unscheduled material events or corporate event	Mar 14, 2019	View HTML 0001193125-19-073987.pdf 0001193125-19-073987.rtf 0001193125-19-073987.xls
10-KT	Annual transition reports filed rule 13a-10 or 15d-10 of the Securities Exchange Act	Mar 18, 2019	View HTML 0001193125-19-078454.pdf 0001193125-19-078454.rtf 0001193125-19-078454.xls EX-101.INS - XBRL INSTANCE DOCUMENT
4	Statement of changes in beneficial ownership of securities	Mar 21, 2019	View HTML 0001562180-19-002006.pdf 0001562180-19-002006.rtf
4	Statement of changes in beneficial ownership of securities	Mar 21, 2019	View HTML 0001562180-19-002007.pdf 0001562180-19-002007.rtf
424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Mar 27, 2019	View HTML 0001193125-19-088540.pdf 0001193125-19-088540.rtf 0001193125-19-088540.xls
424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Mar 29, 2019	View HTML 0001193125-19-092951.pdf 0001193125-19-092951.rtf 0001193125-19-092951.xls
4	Statement of changes in beneficial ownership of securities	Apr 01, 2019	View HTML 0001562180-19-002054.pdf 0001562180-19-002054.rtf
4	Statement of changes in beneficial ownership of securities	Apr 01, 2019	View HTML 0001562180-19-002053.pdf 0001562180-19-002053.rtf

Data provided by Kaleidoscope.